Odomzo (Sun Pharma Global FZE)


Welcome to the PulseAid listing for the Odomzo drug offered from Sun Pharma Global FZE. This Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sun Pharma Global FZE
NON-PROPRIETARY NAME: sonidegib
SUBSTANCE NAME: SONIDEGIB PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-09-21
END MARKETING DATE: 0000-00-00


Odomzo HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOdomzo from Sun Pharma Global FZE
LABELER NAME: Sun Pharma Global FZE
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2017-09-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 47335-303_4133d373-2c2d-4500-9642-dec58b1af4ce
PRODUCT NDC: 47335-303
APPLICATION NUMBER: NDA205266

Other SONIDEGIB PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Pharmaceuticals CorporationOdomzo
Sun Pharma Global FZEOdomzo